News

CEO turned informant: How the FDA built a case against executives promising cheap medications

CNBC

The federal case against an alleged illegal prescription drug operation and its two top leaders earlier this month features a notable informant: the CEO of a peer company that authorities say was committing the same import violations. John Thomas Howard, treasurer and director of a Canadian healthcare company called CANARX, was arrested in the tunnel connecting Detroit and Canada on Nov. 8 and charged with smuggling, conspiracy and importing a misbranded drug for patient use in the United States. His brother and the president of the company, Bob Howard, is wanted on similar charges and was still being sought as of last week, according to court records. The charges mark the first criminal case by U.S.

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.